bionity.com News

Chiesi Group, an international research-focused biopharmaceutical group, and KalVista Pharmaceuticals, Inc., announced that the companies have entered into a definitive agreement under which Chiesi will acquire KalVista (the “Transaction”). The Transaction was unanimously approved by both Chiesi’s a...

It’s well known that chronic stress can disrupt bowel function, sending people running to the bathroom or making them constipated. New research presented at Digestive Disease Week® (DDW) 2026 suggests that eating late at night amplifies these effects, with implications for both digestive health and ...

A team led by metabolism researcher Prof Timo D. Müller at Helmholtz Munich has developed a new approach for treating obesity and type 2 diabetes: a hybrid molecule uses the well-known GLP-1/GIP signalling pathway as a “door opener” and delivers an additional metabolic modulator specifically into th...

Artificial intelligence (AI) is also increasingly being used for health issues. Many people use tools such as ChatGPT to classify complaints and assess whether they need medical help immediately, should seek medical advice or can wait and see. With versions specifically positioned for the healthcare...

A new report by Leaps by Bayer, Boston Consulting Group (BCG), and Ipsos UK provides a deeper understanding of why people respond differently to emerging technologies and what innovators can do to build trust and legitimacy. Based on in-depth interviews in China, Germany, and the United States, the ...

The 18th BioVaria brought a record 360 participants from across the international life-science community to Munich. As Europe's leading platform for commercially promising academic innovations, BioVaria connects researchers, entrepreneurs, investors, and industry partners - accelerating the path fro...

A new report by Leaps by Bayer, Boston Consulting Group (BCG), and Ipsos UK provides a deeper understanding of why people respond differently to emerging technologies and what innovators can do to build trust and legitimacy. Based on in-depth interviews in China, Germany, and the United States, the ...

Leipzig-based biotech start-up Primogene GmbH has secured €4.1 million in funding to bring complex bioactive molecules to market at scale. Using proprietary enzymatic platform technology, the company produces biomolecules that are identical to their natural counterparts, sustainably, cost-efficientl...

Leipzig-based biotech start-up Primogene GmbH has secured €4.1 million in funding to bring complex bioactive molecules to market at scale. Using proprietary enzymatic platform technology, the company produces biomolecules that are identical to their natural counterparts, sustainably, cost-efficientl...

The 18th BioVaria brought a record 360 participants from across the international life-science community to Munich. As Europe's leading platform for commercially promising academic innovations, BioVaria connects researchers, entrepreneurs, investors, and industry partners - accelerating the path fro...

An international research team led by Florence Bansept in cooperation with the Max Planck Institute for Evolutionary Biology has shown how microbes ingested through food may help maintain gut microbiome diversity. The study was first-authored by Vitor M. Marquioni and provides a mathematical framewo...

An international research team led by Florence Bansept in cooperation with the Max Planck Institute for Evolutionary Biology has shown how microbes ingested through food may help maintain gut microbiome diversity. The study was first-authored by Vitor M. Marquioni and provides a mathematical framewo...

Sanofi's Mixed General Meeting of Shareholders convened on April 29, 2026, under the chairmanship of Frédéric Oudéa. All resolutions were approved with a high level of shareholder support, in particular the appointment of Belén Garijo as a board member. In line with the Board’s decision of February ...

Sanofi's Mixed General Meeting of Shareholders convened on April 29, 2026, under the chairmanship of Frédéric Oudéa. All resolutions were approved with a high level of shareholder support, in particular the appointment of Belén Garijo as a board member. In line with the Board’s decision of February ...

mbiomics GmbH, a TechBio company developing scalable, microbiome-based therapeutics for severe and chronic diseases, announced the successful third closing of its Series A financing round of EUR 12 million, bringing the total volume of the round to EUR 30 million. Several existing investors, includi...

mbiomics GmbH, a TechBio company developing scalable, microbiome-based therapeutics for severe and chronic diseases, announced the successful third closing of its Series A financing round of EUR 12 million, bringing the total volume of the round to EUR 30 million. Several existing investors, includi...

New research from Monash University, the University of São Paulo and Deakin University shows a diet high in heavily processed foods can negatively impact the brain’s ability to focus and increases the risk of developing dementia. The study published in Alzheimer’s & Dementia: Diagnosis, Assessment &...

New research from Monash University, the University of São Paulo and Deakin University shows a diet high in heavily processed foods can negatively impact the brain’s ability to focus and increases the risk of developing dementia. The study published in Alzheimer’s & Dementia: Diagnosis, Assessment &...

Researchers at Deutsches Elektronen-Synchrotron (DESY), working with international partners, have developed a new laser system that could significantly simplify multicolour two-photon microscopy. The technology is based on a compact ultrafast fibre laser and makes it possible to visualise several ce...

Researchers at Deutsches Elektronen-Synchrotron (DESY), working with international partners, have developed a new laser system that could significantly simplify multicolour two-photon microscopy. The technology is based on a compact ultrafast fibre laser and makes it possible to visualise several ce...